Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Oncology|January 25, 2000
Phase II study of irinotecan and cisplatin as first-line chemotherapy in advanced or recurrent cervical cancerT Sugiyama, M Yakushiji, K Noda, et al.
British Journal of Cancer|December 16, 2010
Carbonic anhydrase IX (CA-IX) and high-risk human papillomavirus (H-HPV) as diagnostic biomarkers of cervical dysplasia/neoplasia in Japanese women with a cytologic diagnosis of atypical glandular cells (AGC): a Gynecologic Oncology Group (GOG) StudyS-Y Liao, W H Rodgers, J Kauderer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2001
Mutational analysis of BRCA1 and BRCA2 and clinicopathologic analysis of ovarian cancer in 82 ovarian cancer families: two common founder mutations of BRCA1 in Japanese populationM Sekine, H Nagata, S Tsuji, et al.
Human Molecular Genetics|July 7, 2001
Localization of a novel susceptibility gene for familial ovarian cancer to chromosome 3p22-p25M Sekine, H Nagata, S Tsuji, et al.
Japanese Journal of Cancer Research : Gann|April 1, 1997
Mutational analysis of BRCA1 gene in ovarian and breast-ovarian cancer families in JapanM Takano, H Aida, I Tsuneki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 8, 1998
[Effect of 5'-DFUR used concurrently in radiotherapy and immunotherapy uterine cervical cancer--pilot study. Study of 5'-DFUR for Uterine Cervical Cancer]M Hatae, K Noda, A Yajima, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Clinical features of ovarian cancer in Japanese women with germ-line mutations of BRCA1H Aida, K Takakuwa, H Nagata, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 1, 1996
[Phase II study of paclitaxel (BMS-181339) in patients with ovarian cancer by 3-hour intravenous infusion]K Noda, M Ikeda, R Kudo, et al.
Pageof 5